Espinoza Octavio bought LGND
May 17, 2024 · Form 4 insider transaction
Espinoza Octavio bought 1,544 shares of Ligand Pharmaceuticals Incorporated at $63.62 per share, a transaction worth $98.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,544
Price
$63.62
Total value
$98.2K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 17, 2024
Filing dateMay 17, 2024
Shares owned after23,368
OwnershipDirect
10b5-1 planNo
AmendedNo